Hematology focuses on diseases of the blood, bone marrow, and lymphatic system. Learn about the diagnosis and treatment of anemia, leukemia, and lymphoma.
Send us all your questions or requests, and our expert team will assist you.
The Recovery and Follow-up phase is a critical component of successful acute myelogenous leukemia (AML) care, especially for international patients who rely on coordinated, high‑quality aftercare. At Liv Hospital, our multidisciplinary team designs a personalized roadmap that begins the moment chemotherapy or stem‑cell transplantation ends and continues for years thereafter. Studies show that diligent follow‑up can improve overall survival by up to 20 % in AML survivors, underscoring the importance of a structured plan.
This page explains what patients can expect during the recovery and follow‑up period, outlines the schedule of medical assessments, and provides practical advice on managing side effects, nutrition, physical activity, and emotional wellbeing. Whether you are preparing for discharge or have already returned home, the information below will help you navigate the journey with confidence.
We also highlight the unique services Liv Hospital offers to international patients, including interpreter support, tele‑medicine consultations, and assistance with travel and accommodation, ensuring that your aftercare experience is seamless and stress‑free.
During the first year after AML treatment, close surveillance is essential to detect relapse early and to monitor organ function. The post‑treatment monitoring plan is tailored to each patient’s risk profile, treatment modality, and overall health.
Time After Treatment | Key Assessments | Purpose
|
|---|---|---|
Weeks 1‑2 | Physical exam, CBC, metabolic panel | Assess immediate recovery, detect infections |
Month 1 | Bone marrow aspirate (if indicated), cardiac echo | Evaluate marrow status, cardiac toxicity |
Months 3, 6, 9, 12 | Complete blood count, liver/kidney tests, MRI/CT (as needed) | Long‑term organ monitoring, early relapse detection |
Every 6 months (Year 2‑5) | Blood work, annual PET/CT, endocrine panel | Surveillance for late effects, secondary malignancies |
Annually after Year 5 | Comprehensive health review, survivorship questionnaire | Maintain overall wellbeing, address chronic issues |
All appointments can be coordinated through Liv Hospital’s international patient office, which arranges virtual follow‑up for patients who have returned to their home countries.
Even after remission, many patients experience lingering side effects such as fatigue, mucositis, or graft‑versus‑host disease (GVHD) after stem‑cell transplantation. Effective management of side effects reduces hospital readmissions and improves quality of life.
Liv Hospital’s pharmacy team provides personalized medication counseling, and our on‑site nutritionists can suggest supplements that mitigate specific toxicities. Tele‑consultations are available for ongoing symptom tracking, ensuring rapid adjustments to treatment plans.
Optimal nutrition supports bone‑marrow recovery, immune function, and overall stamina. The nutrition and lifestyle guidelines are evidence‑based and adapted to cultural preferences of our international clientele.
Our dietitians also design meal plans that respect religious or regional dietary restrictions, and they can arrange home‑delivery of medically tailored meals for patients staying in Istanbul during the early recovery weeks.
Regaining strength and mobility is essential for a successful rehabilitation process. A structured exercise program reduces the risk of osteopenia, improves cardiovascular health, and boosts mood.
Liv Hospital’s rehabilitation center is equipped with state‑of‑the‑art robotic therapy devices and offers multilingual physiotherapy staff. Patients can schedule sessions in‑person or continue remotely via video‑guided workouts.
The emotional impact of AML treatment can be profound. Incorporating psychological support into the recovery and follow‑up plan helps patients cope with anxiety, depression, and post‑traumatic stress.
Our survivorship clinic coordinates with primary care physicians in the patient’s home country, ensuring continuity of mental‑health care after discharge.
Even after successful remission, AML survivors remain at risk for secondary malignancies, endocrine disorders, and organ dysfunction. The long‑term surveillance strategy focuses on early detection and proactive management.
Liv Hospital’s oncology nurses maintain a secure electronic health record that can be accessed by authorized clinicians worldwide, facilitating coordinated care across borders.
Liv Hospital combines JCI accreditation, cutting‑edge technology, and a dedicated international patient office to deliver world‑class AML aftercare. Our multidisciplinary teams speak over 20 languages, and we provide comprehensive logistical support—from airport transfers to hotel arrangements—so patients can focus solely on healing.
Ready to start your personalized recovery and follow‑up journey? Contact Liv Hospital’s international patient services today to schedule a virtual consultation and learn how we can support you every step of the way.
Send us all your questions or requests, and our expert team will assist you.
During weeks 1‑2 after AML therapy patients receive a physical exam, CBC and metabolic panel to catch infections early. At month 1 a bone‑marrow aspirate (if needed) and cardiac echo assess marrow status and heart toxicity. Follow‑up visits at months 3, 6, 9 and 12 add liver/kidney tests and MRI/CT as required. From year 2 to 5, appointments occur every six months with blood work, annual PET/CT and endocrine panels. After year 5, an annual comprehensive health review and survivorship questionnaire are performed. All visits can be coordinated in‑person or via tele‑medicine for international patients.
Patients are advised to consume 1.2–1.5 g of protein per kilogram of body weight daily from lean meats, legumes, dairy or plant‑based sources. Hydration of 2‑3 L of water per day is essential unless fluid restrictions apply. Micronutrients such as vitamin D (800‑1000 IU), calcium (1000 mg) and omega‑3 fatty acids help reduce inflammation and support bone‑marrow recovery. Processed foods, excess sugar and alcohol should be limited because they can impair liver function and immune recovery. Dietitians also tailor meal plans to cultural or religious preferences and can arrange home‑delivery of medically tailored meals.
ALL often presents abruptly with systemic symptoms. The most frequent signs include severe fatigue and weakness (80‑90% of patients), recurrent infections (70‑85%), unexplained bruising or bleeding tendencies (60‑75%), bone or joint pain (50‑65%), and enlargement of lymph nodes, liver, or spleen (40‑55%). Additional clues can be fever, night sweats, and rapid weight loss. Pediatric patients typically show bone pain and bruising, whereas adults may first notice persistent fatigue. Prompt medical evaluation of these patterns is crucial for early diagnosis.
Phase 1 (weeks 1‑4) focuses on gentle range‑of‑motion exercises, breathing techniques and light stretching under physiotherapist supervision. Phase 2 (months 2‑3) introduces low‑impact aerobic activity such as stationary cycling for 20‑30 minutes three times a week. Phase 3 (months 4‑6) adds light resistance training targeting major muscle groups twice weekly. Phase 4 (beyond 6 months) creates a maintenance program aligned with personal goals—whether hiking, swimming or returning to sport. Liv Hospital’s rehabilitation center offers robotic therapy devices and multilingual physiotherapists, with options for in‑person or video‑guided sessions.
Survivors should undergo annual low‑dose chest CT scans to screen for secondary lung cancers, colonoscopy every five years, and regular skin examinations for skin cancers. Endocrine monitoring includes yearly thyroid function and glucose tolerance tests. Bone health is assessed with DEXA scans at years 2 and 5 to evaluate osteoporosis risk. Cardiac follow‑up with echocardiograms every two years is advised for patients who received anthracyclines or high‑dose radiation. Liv Hospital’s oncology nurses maintain a secure electronic health record accessible to authorized clinicians worldwide, facilitating coordinated long‑term care.
Prognosis varies by age, genetics, and treatment response. Pediatric patients (1‑10 years, standard risk) achieve approximately 90% five‑year survival due to effective chemotherapy protocols. Adolescents and young adults see 70‑80% survival, while adults over 30 years with high‑risk features have lower rates of 40‑50%. The presence of the Philadelphia chromosome historically worsened outcomes, but the addition of tyrosine‑kinase inhibitors improves five‑year survival to about 55%. Ongoing monitoring for late effects and survivorship programs are essential components of long‑term care.
BlogHematologyApr 08, 2026Did you know that blood disorders affect millions of people worldwide, causing a wide range of health issue...
BlogHematologyApr 07, 2026Every year, over 1.8 million people in the United States get cancer. Hematology oncology is key in fighting...
BlogHematologyApr 06, 2026Pulmonary hemorrhage is a serious condition where blood enters the lung tissue and airways suddenly or over...
BlogHematologyApr 03, 2026Vitamin B12 and folic acid are key nutrients. They help keep red blood cells healthy, support nerve functio...
BlogHematologyApr 03, 2026Vitamin B is key for our health, helping with energy and brain function. At LivHospital, we know how import...
BlogHematologyApr 03, 2026Vitamin B12 and folate (vitamin B9) are essential nutrients for our nerves and for making red blood cells. ...
Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.
Start Chat on WhatsApp or call us at +90 530 510 71 24